Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Thorpe

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Biologicals : Journal of the International Association of Biological Standardization|January 24, 2018
Mass spectrometry analysis reveals differences in the host cell protein species found in pseudotyped lentiviral vectorsSabine Johnson, Jun X Wheeler, Robin Thorpe, et al.
Lancet (London, England)|January 2, 2022
New INN nomenclature for monoclonal antibodiesRaffaella Balocco, Sofia De Sousa Guimaraes Koch, Robin Thorpe, et al.
Cytokine|August 6, 2013
How predictive are in vitro assays for cytokine release syndrome in vivo? A comparison of methods reveals worrying differences in sensitivity and frequency of responseSusan J Thorpe, Richard Stebbings, Lucy Findlay, et al.
Transfusion|March 19, 2008
Anti-D and anti-i activities are inseparable in V4-34-encoded monoclonal anti-D: the same framework 1 residues are required for both reactivitiesSusan J Thorpe, Christine Ball, Bernard Fox, et al.
Immunology|November 19, 2016
Influence of Escherichia coli chaperone DnaK on protein immunogenicityKirsty D Ratanji, Jeremy P Derrick, Ian Kimber, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 3, 2016
Editor's Highlight: Subvisible Aggregates of Immunogenic Proteins Promote a Th1-Type ResponseKirsty D Ratanji, Rebecca J Dearman, Ian Kimber, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 9, 2010
An assessment of biological potency and molecular characteristics of different innovator and noninnovator interferon-beta productsAnthony Meager, Carl Dolman, Paula Dilger, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 13, 2017
Surrogate CD16-expressing effector cell lines for determining the bioactivity of therapeutic monoclonal antibodiesShalom A Gurjar, Jeremy P Derrick, Rebecca J Dearman, et al.
Journal of Immunological Methods|November 10, 2009
Improved in vitro methods to predict the in vivo toxicity in man of therapeutic monoclonal antibodies including TGN1412Lucy Findlay, David Eastwood, Richard Stebbings, et al.
Journal of Immunological Methods|May 14, 2016
Establishment of the first WHO Erythropoietin antibody reference panel: Report of an international collaborative studyMeenu Wadhwa, Daniel T Mytych, Chris Bird, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Biologicals : Journal of the International Association of Biological Standardization|January 24, 2018
Mass spectrometry analysis reveals differences in the host cell protein species found in pseudotyped lentiviral vectorsSabine Johnson, Jun X Wheeler, Robin Thorpe, et al.
Lancet (London, England)|January 2, 2022
New INN nomenclature for monoclonal antibodiesRaffaella Balocco, Sofia De Sousa Guimaraes Koch, Robin Thorpe, et al.
Cytokine|August 6, 2013
How predictive are in vitro assays for cytokine release syndrome in vivo? A comparison of methods reveals worrying differences in sensitivity and frequency of responseSusan J Thorpe, Richard Stebbings, Lucy Findlay, et al.
Transfusion|March 19, 2008
Anti-D and anti-i activities are inseparable in V4-34-encoded monoclonal anti-D: the same framework 1 residues are required for both reactivitiesSusan J Thorpe, Christine Ball, Bernard Fox, et al.
Immunology|November 19, 2016
Influence of Escherichia coli chaperone DnaK on protein immunogenicityKirsty D Ratanji, Jeremy P Derrick, Ian Kimber, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 3, 2016
Editor's Highlight: Subvisible Aggregates of Immunogenic Proteins Promote a Th1-Type ResponseKirsty D Ratanji, Rebecca J Dearman, Ian Kimber, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 9, 2010
An assessment of biological potency and molecular characteristics of different innovator and noninnovator interferon-beta productsAnthony Meager, Carl Dolman, Paula Dilger, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 13, 2017
Surrogate CD16-expressing effector cell lines for determining the bioactivity of therapeutic monoclonal antibodiesShalom A Gurjar, Jeremy P Derrick, Rebecca J Dearman, et al.
Journal of Immunological Methods|November 10, 2009
Improved in vitro methods to predict the in vivo toxicity in man of therapeutic monoclonal antibodies including TGN1412Lucy Findlay, David Eastwood, Richard Stebbings, et al.
Journal of Immunological Methods|May 14, 2016
Establishment of the first WHO Erythropoietin antibody reference panel: Report of an international collaborative studyMeenu Wadhwa, Daniel T Mytych, Chris Bird, et al.
Pageof 8